Skip to main content
Patient journey

Cancer

By The Treatment Registry editors

Cancer treatment varies fundamentally by tumour type, stage, biology (including molecular profile), and patient fitness. Modern oncology is multimodal and increasingly precision-driven, combining surgery, radiotherapy, systemic therapies (chemotherapy, targeted therapy, immunotherapy, hormonal therapy), and supportive care. Continuity of care across the treatment course is critical, which makes cross-border treatment particularly difficult to coordinate.

Treatment ladder

Conservative options are first-line where appropriate; surgical options are typically reserved for cases where lower-tier options are unsuitable or have failed. Decisions are individual and depend on clinical assessment.

Conservative

  • Active surveillance / watchful waiting

    For selected indolent cancers (low-risk prostate, some early thyroid and chronic lymphocytic leukaemia), structured surveillance with intervention deferred until progression. Avoids treatment morbidity in patients who may never need active treatment.

  • Best supportive care

    Symptom-focused care without disease-modifying treatment, appropriate when curative or life-prolonging treatment is not feasible or not in the patient's interest.

Procedural

  • Chemotherapy · View procedure page

    Systemic cytotoxic anti-cancer therapy, delivered as cycles of intravenous or oral drugs. Indications, regimens, and protocols are tumour- and stage-specific.

  • Radiotherapy

    External-beam, brachytherapy, or systemic radioisotopes. Used as primary therapy, adjuvant therapy, or palliation depending on the cancer.

  • Targeted therapy and immunotherapy

    Drugs targeting specific molecular alterations (kinase inhibitors, monoclonal antibodies) or immune checkpoints (PD-1/PD-L1 inhibitors). Eligibility depends on tumour molecular profiling.

Surgical

  • Curative oncologic surgery

    Resection of localised tumour with margins, often combined with regional lymphadenectomy. Cornerstone of curative treatment for most solid tumours when surgically resectable.

  • Cytoreductive (debulking) surgery

    Removal of as much tumour bulk as possible to improve response to subsequent systemic therapy; commonly used in ovarian cancer.

  • Palliative surgery

    Surgery to relieve symptoms (e.g. obstruction, pain) when cure is not the aim.

Related procedures